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ABSTRACT
Objective To assess the cost effectiveness of screening
men aged 65 for abdominal aortic aneurysm.
Design Cost effectiveness analysis based on a
probabilistic, enhanced economic decision analytical
model from screening to death.
Population and setting Hypothetical population of men
aged65invited(ornotinvited)forultrasoundscreeningin
the Danish healthcare system.
Data sources Published results from randomised trials
andobservationalepidemiologicalstudiesretrievedfrom
electronic bibliographic databases, and supplementary
data obtained from the Danish Vascular Registry.
Data synthesis A hybrid decision tree and Markov model
was developed to simulate the short term and long term
effects of screening for abdominal aortic aneurysm
compared with no systematic screening on clinical and
cost effectiveness outcomes. Probabilistic sensitivity
analyses using Monte Carlo simulation were carried out.
Results were presented in a cost effectiveness
acceptability curve, an expected value of perfect
informationcurve,andacurveshowingtheexpected(net)
number of avoided deaths from abdominal aortic
aneurysm over time after the introduction of screening.
The model was validated by calibrating base case health
outcomes and expected activity levels against evidence
from the recent Cochrane review of screening for
abdominal aortic aneurysm.
Results The estimated costs per quality adjusted life year
(QALY) gained discounted at 3% per year over a lifetime
forcostsandQALYswas£43485(€54852;$71160).Ata
willingness to pay threshold of £30000 the probability of
screening for abdominal aortic aneurysm being cost
effectivewaslessthan30%.Onewaysensitivityanalyses
showed the incremental cost effectiveness ratio varying
from £32640 to £66001 per QALY.
Conclusion Screening for abdominal aortic aneurysm
does not seem to be cost effective. Further research is
needed on long term quality of life outcomes and costs.
INTRODUCTION
Rupturedabdominalaorticaneurysmsareresponsible
for up to 2% of deaths among men aged 65 or more.
Overall survival after ruptured abdominal aortic
aneurysm is 80-90%; about 40-50% of deaths occur
before people reach hospital.
12
Implementation of a national screening programme
for abdominal aortic aneurysm in men is on the public
health agenda of many western European countries.
Screening programmes that establish diagnosis
through ultrasonography and offer elective repair
have been advocated becauseabdominalaortic aneur-
ysms rarely give rise to symptoms and so are not diag-
nosed before they rupture. The scientific case for
screening for abdominal aortic aneurysm seems estab-
lished; there is evidence of benefit in men, with a sig-
nificant reduction in related deaths.
1
The cost effectiveness of screening for abdominal
aortic aneurysm may be acceptable, but further analy-
sis is necessary.
1 Within trial cost effectiveness
reported in the Multicentre Aneurysm Screening
Study (MASS), the largest randomised trial of screen-
ing for abdominal aortic aneurysm, after four years of
follow-upwas£28400perlifeyeargained.Theauthors
concluded thattheirresult wasat the marginof accept-
ability according to National Health Service thresh-
olds but that cost effectiveness was expected to
improve substantially over a longer period.
3 The
study did not, however, collect information on quality
adjusted life years (QALYs) gained. Endovascular
repair of aortic aneurysm was not used in the trial but
is increasingly used in elective surgery for abdominal
aortic aneurysm, and the long term costs of unwanted
side effects were not included.
Several health economic decision models of screen-
ing for abdominal aortic aneurysm combining data
from MASS and other randomised trials with other
sources of evidence have been published.
4-12 Inconsis-
tenciesintheinputs,structure,andresultsofthemodel,
together with optimistic assumptions about mortality
and quality of life after elective surgery,and a focus on
short term clinical costs, have made the relevance of
these models for decision making unclear. Accord-
ingly,newresearchoncosteffectivenessofscreeningis
recommended.
11314
High external validity of a modelling approach
could be achieved; ultrasonography is considered the
ideal method for screening for abdominal aortic
1Institute of Public Health, Aarhus
University, Vennelyst Boulevard 6,
8000 Aarhus C, Denmark
2Department of Cardiology,
Aalborg Hospital, Aarhus
University Hospital, Aalborg,
Denmark
3Department of Clinical
Epidemiology, Aarhus University
Hospital, Aalborg, Denmark
4Centre for Applied Health
Services Research and
Technology Assessment,
University of Southern Denmark
5Health Technology Assessment
and Health Services Research,
Centre for Public Health, Central
Region, Denmark
Correspondence to: L Ehlers
le@folkesundhed.au.dk
Cite this as: BMJ 2009;338:b2243
doi:10.1136/bmj.b2243
BMJ | ONLINE FIRST | bmj.com page 1 of 7aneurysm and has been used in all trials of abdominal
aorticaneurysmanddecisionanalyticalmodels.Initial
ultrasound examination and surveillance of patients
with small abdominal aortic aneurysms are managed
by mobile teams of hospital specialists, and screening
programmes are controlled by cardiovascular consul-
tants in public hospitals.
13-15 There are differences
among countries in prevalence of abdominal aortic
aneurysm,
16 cost of emergency repair, and mortality
ratesforelectiverepair,
13butanappropriatemodelling
approach can account for such differences in detailed
sensitivity analyses.
17
We carried out cost effectiveness analyses of a
screening programme for abdominal aortic aneurysm
in men aged 65 on the basis of the development and
evaluationofaprobabilistic,enhancedeconomicdeci-
sionanalytical modelfrominitial ultrasound examina-
tiontodeath.Weappliedevidencefortheeffectiveness
ofscreeningfromMASSwithlongtermempiricaldata
on mortality after surgery for abdominal aortic aneur-
ysmfromtheDanishVascularRegistry.Thestudywas
done from a healthcare perspective to assure compar-
abilitywithotherstudies,andinsensitivityanalyseswe
included costs outside the healthcare sector.
METHODS
We modelled cost effectiveness by combining a deci-
sion tree with Markov modelling of long term
consequences.
18 The model portrayed a cohort of
men aged 65 who could receive an invitation or not
to participate in a hypothetical screening programme
for abdominal aortic aneurysm—that is, incidental
diagnosis of abdominal aortic aneurysm (fig 1). We
used standard decision analysis software (TreeAge
Pro 2007; TreeAge Software, Williamstown, MA).
The hypothetical screening programme was carried
out by a team of mobile ultrasound technicians in a
community setting. The diameter of the aneurysm
was measured and action determined according to
thesize:iftheaneurysmwaslarge(≥5.5cm)thepatient
wasreferredforvascularsurgicalassessment,andifthe
aneurysm was small (3-4.4 cm) or medium sized (4.5-
5.4cm)thepatientwasrescannedregularlyoruntilthe
aneurysm became large. Men with normal aorta were
assumed to be without risk of rupture and were classi-
fied as having no abdominal aortic aneurysm until
death.
In each successive cycle we applied a matrix of tran-
sitional probabilities to determine possible transitions
from each stage. The risk of rupture depended on the
sizeoftheaneurysm—thatis,stateofhealth.Eachyear
the men also had a risk of dying from other causes,
depending on their age. We enhanced the model by
relaxing the Markov assumption; memory was built
into the model using time dependent probabilities of
rupture according to an estimated age distribution of
men aged 65 or more having emergency surgery. The
cycle length was one year.
Wemadethemodelprobabilisticbyapplyingarele-
vant distribution for each variable in the model. To
increase transparency and credibility we used normal
distributionasastartingpointforprobabilities.Asnor-
mal distribution was not appropriate in a simulation
because there would be a non-negligible probability
ofsamplinganimpossiblevalue,inthiscaseaprobabil-
ity below zero, we therefore used the mean and stan-
dard deviation from normal distributions to
approximate β distributions for binomial data and
Dirichlet distributions for multinomial data. For costs
we used “right tailed” γ distributions.
18
To determine the value for the entire process (cost
effectiveness ratio of screening for abdominal aortic
aneurysm) we calculated expected costs and health
outcomes for the screening alternative compared
with the non-screening alternative.
We chose Monte Carlo simulation sampling means
as the preferred way of calculating expected values,
which differ from simple roll back “expected values”
basedonthepointormeanvalueforeachvariable.We
used Monte Carlo simulations to select values at ran-
dom from the specified distributions for model vari-
ables. We calculated expected costs and health
outcomes for the two alternatives over second order
uncertainties for a cohort of 10000 hypothetical men
aged 65.
Data input
The model was based on extensive and detailed data-
sets for all inputs (table 1). We obtained estimates of
the variables required for the model through a sys-
tematic review of the literature.
Standard survival analyses were based on Danish
data on long term mortality after elective surgery and
emergency surgery. We obtained data on incident
cases of abdominal aortic aneurysm from the Danish
VascularRegistryfortheperiod1996-2006andlinked
withdataonvitalstatusfromtheDanishCentralOffice
ofCivilRegistration.
23FromtheDanishVascularReg-
istry we obtained national data on the age distribution
of men having emergency surgery during 1996-2006.
We used quality of life weights from a standard
population of men—that is, a QALY weight of 0.80
for all hypothetical men aged 65-70 and 0.76 for
Decision note
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Markov note
Terminal note
No aneurysm
Small aneurysm
Large aneurysm
Death
Medium sized
aneurysm
After elective
surgery
After emergency
surgery
Attended
screening
Did not attend
screening
Invitation to
screening for
abdominal
aortic aneurysm
No invitation
to screening
Men aged 65
Fig 1 | Decision analytical model of screening for abdominal aortic aneurysm compared with no
systematic screening
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used age adjusted quality of life weights from average
malesmokersof0.71,and0.67formenaged65-70and
those aged more than 70.
24
Costs were in 2007 prices (DKK 9.41; £1.00; €1.26;
$1.78); we applied the cost to the Danish healthcare
system (DRG) for 2007 as best estimate for surgery
cost.
22 Surgery for abdominal aortic aneurysm in the
Danish DRG system comprises three groups: surgery,
emergency surgery, and surgery with death occurring
within 30 days.
Data from the recent Cochrane review of screening
for abdominal aortic aneurysm were used as indepen-
dent calibration data for validation of the model.
1 We
applied tracker variables to the model, and we calcu-
latedtheexpectednumberofavoideddeathsrelatedto
abdominal aortic aneurysm and levels of surgery and
surveillance under the two alternatives and compared
them with Cochrane data. We calculated the average
ageatdeathfromrupturedabdominalaorticaneurysm
in the different patient pathways and calibrated this
against registry data and published data.
Analyses
We presented simulation output in a cost effectiveness
acceptability curve for screening for abdominal aortic
aneurysm, showing the probability of screening being
cost effective at different threshold ratios.
18
For the same Monte Carlo simulation used to con-
struct the cost effectiveness acceptability curve we
further calculated the expected cost of uncertainty
(expected value of perfect information surrounding
the decision). We presented the expected value of per-
fect information for a hypothetical population of
250000 men aged 65. This value illustrates the oppor-
tunitycostofmakingtheincorrectdecision,calculated
asthedifferencebetweentheexpectednetbenefitwith
perfect information and the expected net benefit with
current information. The expected value of perfect
information provides a basis for deciding whether or
not to invest in further research to reduce variable
uncertainty.
18
We carried out one way sensitivity analyses of all
modelvariablesandofseveraladditionalfactorslikely
to influence cost effectiveness.
25 The credible range in
variable estimates was found by a search of the litera-
ture. We included the private cost of transportation;
the unit cost of transportation was £0.36/0.62 miles (1
km) and we assumed 20 km to be the average distance
to and from the screening location, in total £14.00 per
individual. Indirect costs were included assuming that
three hours were spent per screening test, that 37% of
all men aged 65 were employed, and that an average
salary as an estimate of the value of lost productivity
corresponded to £15.90 per attendee. We discounted
cost and effect at 3% to express net present values.
Alternative values (0% and 5%) were applied in sensi-
tivity analyses.
We simulated consecutive cohorts of men aged 65
by summing up expected numbers of deaths related
to abdominal aortic aneurysm and surgical activity to
illustrate the dynamics of the screening programme.
Table 1 |Data inputs and assumptions in Markov model
Variable Mean Distribution* Source
Probability
Prevalence of abdominal aortic
aneurysm ≥3c m
0.04 Normal (α 0.04, σ 0.0051) Lindholt et al
19
Acceptance rate 0.77 Normal (α 0.77, σ 0.0056) Lindholt et al
19
Size of abdominal aortic
aneurysm (initial probability):
Small (3-4.4 cm) 0.71 Normal (α 0.71, σ 0.056)
Multicentre Aneurysm
Screening Study Group
3 Medium (4.5-5.4 cm) 0.17 Normal (α 0.17, σ 0.026)
Large (≥5.5 cm) 0.12 Normal (α 0.12, σ 0.051)
Risk of rupture per year:
Small aneurysm 0.003 Normal (α 0.003, σ 0.0015)
Brown and Powel
20 Medium aneurysm 0.015 Normal (α 0.015, σ 0.0077)
Large aneurysm 0.065 Normal (α 0.065, σ 0.03)
Growth rate per year:
From small to medium 0.115 Normal (α 0.115, σ 0.005) Henriksson and Lundgren,
4
Silverstein et al
5
From medium to large 0.159 Normal (α 0.159, σ 0.006)
30 day mortality:
Elective surgery 0.038 Normal (α 0.038, σ 0.0051) Danish Vascular Registry.
Annual report for 2006
21
Emergency surgery 0.45 Normal (α 0.45, σ 0.0143)
Proportionofpatientswithlarge
abdominal aortic aneurysm
eligible for surgery
0.814 Normal (α 0.814, σ 0.0256) Multicentre Aneurysm
Screening Study Group
3
Proportion of ruptures where
patient reaches hospital alive
0.401 Normal (α 0.401, σ 0.051) Henriksson and Lundgren,
4
Silverstein et al
5
Ad hoc diagnosis of abdominal
aortic aneurysm
0.06 Normal (α 0.06, σ 0.0255) Multicentre Aneurysm
Screening Study Group
3
Cost (£ £)
Elective surgery 10 663 γ (α 86.17, λ 0.0071) Danish DRG casemix system
22
Emergency surgery 12 125 γ (α 93.49, λ 0.0088) Danish DRG casemix system
22
Surgery with death occurring
within 30 days
50 3 8 γ (α 28.5, λ 0.0057) Danish DRG casemix system
22
Cost per invitation 6 — Henriksson and Lundgren
4
Cost per ultrasound
examination
39 — Henriksson and Lundgren
4
£1.00 (DKK 9.41; $1.78; €1.26).
*Mean and standard deviation from normal distributions are used to approximate β and Dirichlet distributions
for simulation purposes.
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Fig 2 | Cost effectiveness acceptability curve of screening for
abdominal aortic aneurysm in hypothetical population of
10000 men aged 65
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lations averaging 10000 second order samples of vari-
able values with 10000 trials (random walks) for each
variable sample. This allowed for uncertainty of vari-
ables and variability. To illustrate the development in
the expected (net) number of avoided deaths over time
asaresultofscreeningforabdominalaorticaneurysmwe
created curves for the first 15 years of consecutive
cohorts of 10000 men aged 65 at the time of screening.
We compared the results of simulating five years of
screening with that of a single cohort followed through-
out life.
RESULTS
At a discounted rate of 3% the incremental cost effec-
tiveness ratio (base case) was £43485 per QALY
(table 2). The incremental cost effectiveness ratio
with one way sensitivity analyses was £32640-
£66001 per QALY (table 2).
Figure 2 presents the Monte Carlosecond order cal-
culationof 10000 hypotheticalmen aged 65.At a will-
ingness to pay threshold of £30000 the probability of
screening being cost effective was less than 30%.
Figure 3 presents the expected value of perfect infor-
mation for a hypothetical population of 250000 men
aged 65. It would be potentially cost effective to carry
outfurtherresearchiftheexpectedvalueofperfectinfor-
mation for this population exceeded the expected costs
of additional research. If, for instance, additional
research was expected to cost £1 m ,t h e ns u c hr e s e a r c h
would be potentially cost effective if the threshold was
greater than £30000.
The expected value of perfect information should be
expressed for the total population of current and future
men who will benefit from the health technology.
Assumingthat screening for abdominalaortic aneurysm
for the next 20 years will be offered to at least 250000
m e na ge d6 5e a c hy ea rinEng l a ndt h eex p e c t e dv al u eo f
perfect information for this total population will be
roughly the expected value of perfect information×20
(undiscounted) or the expected value of perfect informa-
tion×14.9 (discounted), where 14.9 is the annuity factor
for a period of 20 years with an interest rate of 3%. For
even larger (international) populations the curve will be
shifted furtherupward,suggestingthat itmorelikelywill
be considered cost effective to achieve better informa-
tion. This reflects that research knowledge has so called
public good characteristics.
18
The results of the model simulation of a cohort of
10000 men followed through life were consistent with
those from published randomised trials (table 3).
13
Assuming about 250000-300000 men aged 65 in Eng-
land were followed, an expected 675-810 deaths related
to abdominal aortic aneurysm would be avoided which
is similar to the present expectancy of the NHS. Other
simulation results for the non-screening alternative—for
example,estimatedmeanageatrupture(74years),mean
age at death due to rupture (75 years), and mean age at
deathafterelectivesurgerywithoutscreeningforabdom-
inal aortic aneurysm (71 years), were consistent with
published data.
2829
Theexpectedresultfiveyearsaftertheintroductionof
screening(thatis,fiveconsecutivecohortsof10000men
aged65)showsanincreaseofninetotalnumberofdeaths
related to abdominal aortic aneurysm as a side effect of
the increased number of elective operations in the short
Table 2 |Incremental cost effectiveness ratio (base case) and selected one way sensitivity
analyses of screening men aged 65 for abdominal aortic aneurysm
Scenario £/QALY
Base case
Prevalence: 43 485
2% 57 169
3% 48 049
5% 40 742
Probability of reaching hospital alive with rupture:
Low (30%) 32 640
High (50%) 66 001
30 day mortality after elective surgery:
Low (2.5%) 36 128
High (5%) 54 808
Incidental screening for abdominal aortic aneurysm:
Low (5% per year) 45 366
High (7% per year) 42 018
Acceptance:
Low (60%) 43 920
High (80%) 43 163
Proportion of aneurysms >5.5 cm:
Low (8%) 52 785
High (16%) 37 571
Discount rate:
Low (0%) 47 334
High (5%) 46 478
Proportion eligible for elective repair:
Low (−10%) 45 508
High (+10%) 42 372
Cost of emergency surgery:
Low (−25%) 43 855
High (+25%) 43 115
Cost of elective repair:
Low (−25%) 39 877
High (+25%) 47 140
Cost of surgery with death occurring within 30 days:
Low (−25%) 44 595
High (+25%) 42 421
Cost of invitation:
Low (−50%) 42 236
High (+50% ) 44 919
Cost of ultrasound examination:
Low (−50%) 36 731
High (+50%) 50 470
QALY weights:
Low (−10%) 48 308
High (+10%) 42 372
As average smokers
24 49 412
Including costs of endovascular repair of aortic aneurysm in 25%
of elective repairs
26
56 623
Including cost of future health care of smokers
27 48 527
Including cost of patient transport and indirect cost 54 403
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first five years).
Figure 4 illustrates the (net) number of avoided
deaths over time after the introduction of screening
formenaged65.Thecurveshowsanincreaseindeaths
in the first eight years, assuming that eight successive
cohorts of 10000 men aged 65 were screened. This
curve illustrates the time lag between implementation
of and the realisation of future benefits from screening
for abdominal aortic aneurysm.
DISCUSSION
Weconstructedadecisionanalyticalmodeltoevaluate
the cost effectiveness of screening men aged 65 for
abdominal aortic aneurysm. The incremental cost
effectiveness ratio (base case) was £43485 per QALY.
At a willingness to pay threshold of £30000 the prob-
ability of screening being cost effective was less than
30%. One way sensitivity analyses showed the incre-
mentalcosteffectivenessratiovaryingfrom£32640to
£66001 per QALY. A screening programme was
therefore unlikely to be cost effective.
Strengths and limitations of the study
Our decision analytical framework was based on best
evidence of effectiveness and costs, including registry
dataforlongtermmortalityafterelectiveandemergency
repair of abdominal aortic aneurysm, and age distribu-
tionofrupturedabdominalaorticaneurysm.TheDanish
VascularRegistry hasbeen shown to havea high degree
of validity.
30
We validated the model by calibrating against key
values from the Cochrane review of effectiveness of
screening for abdominal aortic aneurysm.
1 The number
of avoided deaths, amount of elective and emergency
surgery, and mean age at surgery were consistent with
pooled data from randomised trials and clinical data.
Estimated age at rupture, at death due to rupture, and
at death after elective surgery in the non-screening alter-
native were also consistent with published data.
Decision analytical models provide several advan-
t a g e sc o m p a r e dw i t he c o n o m i ce v a l u a t i o n sa l o n g s i d e
clinical trials; evidence from multiple sources can be
combined and systematic sensitivity analyses done.
1823
None of the randomised trials of screening for abdom-
inal aortic aneurysm collected information on QALY
gains and long term costs; endovascular repair of aortic
aneurysm was not used in the trials and accordingly not
included in the cost calculations in published health eco-
nomic studies of screening for abdominal aortic aneur-
ysm.Aorticstentsareincreasinglyusedinmanyvascular
departments in western European countries. Endo-
vascular repair may be cost effective in patients who
a r eu n f i tf o ro p e nr e p a i r ,b u ti ti su s e di n c r e a s i n g l ya sa
substituteforconventionalopenrepair.
26Sensitivityana-
lyses showed that including the cost of graft surveillance
and secondary procedures after endovascular repair sig-
nificantly increased the cost per QALY gained from
screening for abdominal aortic aneurysm.
One limitation of our modelling approach was that it
relies on a combination of data from studies in different
countries, gross costing, and average QALY
weights.
171825 Another limitation was the focus on
screeningallmenaged65.Wedidconsiderdoingsimilar
analysesinhighriskgroupssuchassmokersbutthedata
were unavailable.
Comparison with other studies
Ourestimateoftheincrementalcosteffectivenessratiois
comparable to the within trial cost effectiveness ratio
reported in MASS of £28400 per life year gained
(equivalent to about £36000 per QALY).
3 The main
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Fig 3 | Expected value of perfect information (EVPI) for
hypothetical population of 250000 men aged 65
Table 3 |Expected level of activity in men aged 65 with or without screening for abdominal
aortic aneurysm
Variable
Single cohort of men
aged 65 (lifetime
perspective) Difference
Five consecutive
cohorts of men aged
65 (5 year
accumulated) Difference
No of men invited 10 000 — 50 000 —
No of attendees (No of
ultrasound examinations)
6670 — 26 680 —
No of patients screened:
Abdominal aortic
aneurysm identified
267 — 1067 —
Under surveillance* 240 — 903 —
No of elective operations:
With screening 151
96
238
196
Without screening 55 42
No of deaths after elective
surgery†:
With screening 12
8
18
15
Without screening 4 3
No of deaths after
emergency surgery‡:
With screening 47
−35
30
−7
Without screening 82 37
TotalNoofdeathsrelatedto
abdominalaorticaneurysm:
With screening 59
−27
49
9
Without screening 86 40
*Individuals with an identified abdominal aortic aneurysm who cannot be offered elective surgery because of
contraindications.
†Counted as one year mortality (which amounts to about double the 30 day mortality). Number of deaths with
screening includes non-attendees.
‡Counted as one year mortality. The average age at death from ruptured abdominal aortic aneurysm is
estimated to be about 75 years in model without screening.
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The results in MASS were presented as a weighted aver-
age for the entire group of men aged 65-74, which is not
thesameasscreeningmenaged65.Alowerincremental
cost effectiveness ratio was therefore reported in that
study.Otherreasonsaredifferencesinthecostofelective
and emergency surgery and the application of different
discount rates for costs and health outcomes in MASS.
3
O u re s t i m a t ei sn o tc o m p a r a b l ew i t hp r e v i o u sm o d e l -
ling studies, which in general claim that screening for
abdominal aortic aneurysm is cost effective.
4-12 We
believe our study provides a more realistic estimate of
cost effectiveness. For instance, previous studies did not
use enhanced Markov models with time dependency
built into the transitional probabilities, nor could they
provide solid evidence of model validity.
1314
Implications
This study does not support the widespread conception
that screening for abdominal aortic aneurysm is cheap.
Ultrasonography may be cheap on a per person basis,
but screening is not just a test but a programme with
several interdependent activities. If screening is to be
effective then overall administration of the programme,
operational planning, a communication strategy, a qual-
ity assurance system,and more are needed. To carry out
systematictestingofalargepopulation,severalscreening
locations and arrangements for transportation are
required to gain wider geographical coverage. Equally
importantly, ultrasonography leads to a large number
of patients unfit for surgery with a need for continued
observation under care of a vascular surgeon.
Further research
Accordingtotheexpectedvalueofperfectinformation
in fig 3, additional research may be cost effective.
Uncertainty surrounds several key variables, with the
risk that a wrong decision might be made.
Firstly,weassumedinaccordancewithearlierhealth
economic studies that patients with abdominal aortic
aneurysm could return to a quality of life comparable
to the average population: there is only poor evidence
for this assumption.
2 None of the randomised trials on
abdominal aortic aneurysm systematically measured
QALY gains, so we cannot be sure that screening for
abdominal aortic aneurysm provides the expected
QALY gains. More than 90% of patients with abdom-
inal aortic aneurysm have a history of smoking, and
assuming that all patients gain a quality of life after
aneurysm repair comparable to the average age
matched population seems to conflict with public
health evidence that smokers experience a lower qual-
ity of life in their remaining years.
2427 Secondly, no
study has determined the long term healthcare cost
afterhospitaldischargeforelectiverepairofanabdom-
inalaorticaneurysm.Thisincludeslongtermcareafter
major surgical complications such as stroke, chronic
renal failure, major amputation, and cardiac infarc-
tions, which occur in 1-5% of patients after elective
surgery.
6 Thus these costs might be high if a screening
programme for abdominal aortic aneurysm is imple-
mented. Thirdly, since the late 1990s considerable
interest has been shown in smoking cessation pro-
grammes. The effect of national antismoking laws
and campaigns for smoking cessation and the increase
inadhocdetectionofabdominalaorticaneurysmcases
asimagingbecomesmorewidelyutilisedforotherrea-
sons, may reduce the prevalent pool of undiagnosed
abdominal aortic aneurysms and hence the effective-
ness of screening.
Noticeably,table 2showstheincrementalcosteffec-
tivenessratiotobequiteinsensitivetoonewaychanges
in variable values—that is, even large changes in vari-
able values do not change the conclusion. The most
influential variable seems to be the probability of
reaching hospital alive in case of rupture. This robust-
nessoftheresultpointstotheneedforfurtherresearch
on alternatives to mass screening.
Conclusion
Screeningmenaged65forabdominalaorticaneurysm
was not cost effective; the incremental cost effective-
ness ratio was £43485 per QALY (range £32640-
£66001 per QALY). At a willingness to pay threshold
of £30000 per QALY the probability of screening for
abdominal aortic aneurysm being cost effective was
less than 30%. The expected value of perfect
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Fig 4 | Simulation of expected (net) number of avoided deaths
from abdominal aortic aneurysm after screening 15
consecutive cohorts of 10000 men aged 65. Expected (net)
number of avoided deaths are calculated as the difference in
total expected number of deaths due to ruptured abdominal
aortic aneurysm and deaths due to elective surgery under the
two alternatives
WHAT IS ALREADY KNOWN ON THIS TOPIC
One time ultrasound screening of men aged 65 or more can significantly reduce mortality
from ruptured abdominal aortic aneurysm
It is uncertain whether screening all 65 year old men is cost effective
WHAT THIS STUDY ADDS
Screening men aged 65 for abdominal aortic aneurysm was not cost effective
The incremental cost effectiveness ratio was £43485 per QALY (range £32640-£66001 per
QALY)
At a willingness to pay threshold of £30000 per QALY there was a less than 30% probability
of screening being cost effective
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is needed.
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